Invitation to presentation of Permascand’s Q2 2023 interim report

Permascand will publish its Q2 2023 interim report on 16 August 2023 at 07:45 CEST. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CEST.

The presentation will be held by CEO Peter Lundström and CFO Linda Ekman in English and will conclude with a Q&A session. Questions can be asked on the conference call or in written form through the webcast.

Date and time
16 August 2023 at 10:30 CEST

Webcast
https://ir.financialhearings.com/permascand-top-holding-q2-2023

Registration
To participate via teleconference, please register via the link below. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

https://conference.financialhearings.com/teleconference/?id=200910

After the presentation, a recording of the webcast will be available on the webcast link and on the company’s website www.permascand.com

Permascand strengthens its presence in North America by signing a collaboration and supply agreement with Chemetry and investing as growth partner

Permascand has signed a collaboration and supply agreement with Chemetry, a company focused on developing lower energy technologies in the chemical space, based in Moss Landing, California. As part of the agreement, Permascand has acquired shares in Chemetry. The agreement is in line with Permascand’s strategy to further grow its Industrial Solutions segment in the North American market through technological and business development partnerships.

The collaboration and supply agreement, and the investment, are the next steps following the successful collaboration between Permascand and Chemetry concerning the commercialization of electrochemical cells for Chemetry's eShuttle® EDC technology. The eShuttle® platform combines electrochemistry and catalysis to enable more sustainable process technologies for commodity chemicals.

“Through this collaboration and supply agreement, and the related investment in Chemetry, Permascand takes the next step in our strategic plan to strengthen our presence on the North American market. We believe this is making us more competitive in gaining market shares by winning new projects and related aftermarkets services going forward. Additionally, it enables us to use our expertise to support the development of new state of the art technology for the electrochemical markets, which will support our customers to lower their energy consumption and meet future environmental requirements”, said Peter Lundström, CEO at Permascand.

”The strategic collaboration with Permascand adds an important partner to Chemetry’s team and is the next step for Chemetry in the commercialization of the first application of the eShuttle® platform for production of ethylene dichloride (EDC), an essential chemical in the manufacturing of PVC plastic. This collaboration positions us to supply our electrolysis technology to the industry and to provide technology support and expertise in all aspects of our business, said Ron Birkhoff, CEO at Chemetry.

The consideration of the acquired Chemetry shares amount to approximately SEK 10,2 million.

About Chemetry
Chemetry is a chemical technology company, based in California, that focuses on developing innovative and sustainable processes for the production of essential chemicals. Chemetry’s proprietary technology platform, called eShuttle®, offers several advantages over traditional production routes, including lower energy consumption, lower CO2 emissions, and lower cost of production. For more information, visit www.chemetrycorp.com.

Bulletin from Annual General Meeting in Permascand Top Holding AB

At the Annual General Meeting in Permascand Top Holding AB, Reg. No. 559227-6124 (the “company”), on 9 May 2023 in Ljungaverk, it was resolved in accordance with the below. For more detailed information on the content of the resolutions, please refer to the notice of the Annual General Meeting, which is available on the company’s website, www.permascand.com.

Adoption of the income statement and balance sheet
It was resolved to adopt the income statement and balance sheet and the consolidated income statement and balance sheet for the financial year 2022.

Resolution on dispositions of the company’s result
It was resolved, in accordance with the Board’s proposal, that no dividend shall be paid for the financial year 2022 and that available profits shall be carried forward.

Resolution on discharge from liability
It was resolved to discharge all members of the Board of Directors and the Chief Executive Officer from liability for the management of the company's affairs for the financial year 2022.

Determination of the number of Board members and auditors
It was resolved that the number of members of the Board of Directors elected by the general meeting shall be seven (7) and that one (1) registered auditing company shall be appointed as auditor.

Fees to the Board members and the auditors
It was resolved that fees to the members of the Board of Directors shall be as follows:

  • SEK 570,000 to the Chairman of the Board and SEK 235,000 to each of the other Board members elected by the Annual General Meeting who are not employed by the company; and
  • SEK 115,000 to the Chairman of the Audit Committee and SEK 30,000 to each of the other members of the Audit Committee, and SEK 60,000 to the Chairman of the Remuneration Committee and SEK 20,000 to each of the other members of the Audit Committee.

It was resolved that the auditor’s fees shall be paid as per approved invoice.

Election of Board members and auditors
It was resolved to re-elect Per Lindberg, Anna Alexandersson, Karl Bergman, Marie Grönborg, Mario Houde, Ingar Jensen and Johan Karlsson as Board members for the period until the end of the next Annual General Meeting. Per Lindberg was re-elected Chairman of the Board.

It was resolved to re-elect the registered auditing company KPMG AB as auditor for the period until the end of the next Annual General Meeting with Helena Nilsson as auditor in charge.

Resolution on guidelines for remuneration to senior executives
It was resolved to adopt guidelines for remuneration to senior executives which, compared to the previously applicable guidelines, mean that variable cash payments to the Chief Executive Officer shall entitle to pension.

Resolution on issue authorization
It was resolved to authorize the Board of Directors to, on one or several occasions during the period up until the next Annual General Meeting, resolve on issue of shares, warrants and/or convertible instruments, with or without deviation from the shareholders’ preferential rights. The total number of shares that are issued by support of the authorization, including shares that may be issued after exercise of warrants or conversion of convertible instruments issued by support of the authorization, may correspond to at most ten (10) percent of the total number of shares in the company at the time of the first utilization of the authorization. Payment may, in addition to cash payment, be made in kind or by set-off, or otherwise with conditions.

The purpose of the authorization and the reasons for any deviation from the shareholders’ preferential rights is to increase the company’s financial flexibility and the Board’s room for maneuver to raise capital in a time- and cost-effective manner and/or complement the shareholder base with new shareholders of strategic importance for the company, and enable the company to, fully or partially, finance any company acquisitions or acquisitions of businesses by issuing financial instruments as payment in connection with acquisitions, or to raise capital for such acquisitions. Issues made with deviation from the shareholders’ preferential rights shall take place at a subscription price in line with market conditions, including any discount in line with market conditions where applicable. If the Board of Directors deems it appropriate in order to enable the delivery of shares in connection with an issue as described above, the issue may be done at a subscription price equal to the quota value of the share.

Invitation to presentation of Permascand’s Q1 2023 interim report

Permascand will publish its Q1 2023 interim report on 10 May 2023 at 07:45 CEST. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CEST.

The presentation will be held by CEO Peter Lundström and CFO Linda Ekman in English and will conclude with a Q&A session. Questions can be asked on the conference call or in written form through the webcast.

Date and time
10 May 2023 at 10:30 CEST

Webcast
https://ir.financialhearings.com/permascand-top-holding-q1-2023

Registration
To participate via teleconference, please register via the link below. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

https://conference.financialhearings.com/teleconference/?id=200746

After the presentation, a recording of the webcast will be available on the webcast link and on the company’s website www.permascand.com

Trading update on the current market situation for Permascand during the first quarter of the year

Permascand communicated in connection with the Year-end report on February 9, 2023, that the company expects declining revenues in Water Treatment. The situation has been further reinforced, and the company is experiencing significantly weaker and declining demand than expected, and estimates that the installation cycle in ballast water treatment has reached its peak.

The first quarter of 2023 is characterized by a turbulent environment where customers in all segments are cautious in their investment decisions, which has affected the company negatively with a lower order intake than expected.

Permascand continues to experience strong market interest in the Electrification & Renewables and Industrial Solutions segments. These segments account for an increasing share of Permascand's revenue mix and customer demand is good. However, these revenues do not compensate for the loss of revenues in the Water Treatment segment.

Permascand's interim report for January-March will be published as planned on May 10, 2023.